IDEAS home Printed from https://ideas.repec.org/a/eee/respol/v39y2010i10p1277-1288.html
   My bibliography  Save this article

Global health social technologies: Reflections on evolving theories and landscapes

Author

Listed:
  • Chataway, Joanna
  • Hanlin, Rebecca
  • Mugwagwa, Julius
  • Muraguri, Lois

Abstract

This paper has two core purposes. First, building on Nelson and Sampat's work, we outline the social technology conceptual framework and explain why we favour using it to explore two global health initiatives. Second, we discuss the evolution of those initiatives through the lens of the interaction between social technologies, physical technologies and general institutions. Thus we reflect both on evolving conceptual landscapes on the one hand and organisational and institutional terrains on the other. The first section of the paper presents an intellectual journey and outlines our understanding and adoption of the social technology conceptual framework. This framework we argue has a number of advantages over alternative theoretical approaches and perspectives. The second section describes the context in which product development partnerships (PDPs), a type of global health initiative based on a public-private partnership (PPP), have arisen. The third section develops case studies of the International AIDS Vaccine Initiative (IAVI) and the Malaria Vaccines Initiative (MVI) as social technology experiments and looks at the complex dynamics between organisation, management, scientific and R&D success and general institutional environments. We look at these social technologies as having 'integrator' and 'broker' roles; classifications which we argue are useful in analysing the different roles taken on by these PDPs. In the conclusion we reflect on the useful ways in which the concept of social technologies can shed light on complex and networked initiatives.

Suggested Citation

  • Chataway, Joanna & Hanlin, Rebecca & Mugwagwa, Julius & Muraguri, Lois, 2010. "Global health social technologies: Reflections on evolving theories and landscapes," Research Policy, Elsevier, vol. 39(10), pages 1277-1288, December.
  • Handle: RePEc:eee:respol:v:39:y:2010:i:10:p:1277-1288
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0048-7333(10)00171-X
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Joanna Chataway & Stefano Brusoni & Eugenia Cacciatori & Rebecca Hanlin & Luigi Orsenigo, 2007. "The International AIDS Vaccine Initiative (IAVI) in a Changing Landscape of Vaccine Development: A Public/Private Partnership as Knowledge Broker and Integrator," The European Journal of Development Research, Taylor and Francis Journals, vol. 19(1), pages 100-117.
    2. Rodrik, Dani, 2004. "Industrial Policy for the Twenty-First Century," CEPR Discussion Papers 4767, C.E.P.R. Discussion Papers.
    3. Cockburn, Iain M & Henderson, Rebecca M, 1998. "Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery," Journal of Industrial Economics, Wiley Blackwell, vol. 46(2), pages 157-182, June.
    4. Nelson, Richard R. & Sampat, Bhaven N., 2001. "Making sense of institutions as a factor shaping economic performance," Journal of Economic Behavior & Organization, Elsevier, vol. 44(1), pages 31-54, January.
    5. Iain M. Cockburn & Rebecca M. Henderson, 1998. "Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery," Journal of Industrial Economics, Wiley Blackwell, vol. 46(2), pages 157-182, June.
    6. Galambos, Louis & Sturchio, Jeffrey L., 1998. "Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation," Business History Review, Cambridge University Press, vol. 72(2), pages 250-278, July.
    7. Metcalfe, Stan & Ramlogan, Ronnie, 2008. "Innovation systems and the competitive process in developing economies," The Quarterly Review of Economics and Finance, Elsevier, vol. 48(2), pages 433-446, May.
    8. Gambardella,Alfonso, 1995. "Science and Innovation," Cambridge Books, Cambridge University Press, number 9780521451185.
    9. Hannah Kettler;Adrian Towse, 2002. "Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty," Monograph 000479, Office of Health Economics.
    10. Mazzoleni, Roberto & Nelson, Richard R., 2007. "Public research institutions and economic catch-up," Research Policy, Elsevier, vol. 36(10), pages 1512-1528, December.
    11. Nelson, Richard R., 2008. "What enables rapid economic progress: What are the needed institutions," Research Policy, Elsevier, vol. 37(1), pages 1-11, February.
    12. Chataway, Joanna & Smith, James, 2006. "The International AIDS Vaccine Initiative (IAVI): Is It Getting New Science and Technology to the World's Neglected Majority?," World Development, Elsevier, vol. 34(1), pages 16-30, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Williams, Christopher, 2021. "Global human burden and official development assistance in health R&D: The role of medical absorptive capacity," Research Policy, Elsevier, vol. 50(10).
    2. Il-haam Petersen, 2016. "Achieving Co-Operation in an Aid-Funded Development Network Organisation (DNO): Lessons for Development Practitioners," The European Journal of Development Research, Palgrave Macmillan;European Association of Development Research and Training Institutes (EADI), vol. 28(5), pages 916-933, November.
    3. Fonseca, Elize Massard da & Shadlen, Kenneth C. & Achcar, Helena de Moraes, 2023. "Vaccine technology transfer in a global health crisis: Actors, capabilities, and institutions," Research Policy, Elsevier, vol. 52(4).
    4. van der Have, Robert P. & Rubalcaba, Luis, 2016. "Social innovation research: An emerging area of innovation studies?," Research Policy, Elsevier, vol. 45(9), pages 1923-1935.
    5. Paola Perez-Aleman & Tommaso Ferretti, 2023. "Creating innovation capabilities for improving global health: Inventing technology for neglected tropical diseases in Brazil," Journal of International Business Policy, Palgrave Macmillan, vol. 6(1), pages 84-114, March.
    6. Coburn, Josie & Yaqub, Ohid & Chataway, Joanna, 2022. "Targeting research to address societal needs: What can we learn from 30 years of targeting neglected diseases?," SocArXiv 65ws7, Center for Open Science.
    7. Joanna Chataway & Sarah Parks & Elta Smith, 2017. "How Will Open Science Impact on University-Industry Collaboration?," Foresight and STI Governance (Foresight-Russia till No. 3/2015), National Research University Higher School of Economics, vol. 11(2), pages 44-53.
    8. Elsie Onsongo & Johan Schot, 2017. "Inclusive Innovation and Rapid Sociotechnical Transitions: The Case of Mobile Money in Kenya," SPRU Working Paper Series 2017-07, SPRU - Science Policy Research Unit, University of Sussex Business School.
    9. Ohid Yaqub, 2018. "Variation in the dynamics and performance of industrial innovation: what can we learn from vaccines and HIV vaccines?," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 27(1), pages 173-187.
    10. Woodson, Thomas S., 2016. "Public private partnerships and emerging technologies: A look at nanomedicine for diseases of poverty," Research Policy, Elsevier, vol. 45(7), pages 1410-1418.
    11. Hu, Mei-Chih & Kang, Jin-Su & Wu, Ching-Yan, 2017. "Determinants of profiting from innovation activities: Comparisons between technological leaders and latecomers," Technological Forecasting and Social Change, Elsevier, vol. 116(C), pages 223-236.
    12. Aguirre-Bastos, Carlos & Weber, Matthias K., 2018. "Foresight for shaping national innovation systems in developing economies," Technological Forecasting and Social Change, Elsevier, vol. 128(C), pages 186-196.
    13. Ohid Yaqub & Javier A Luna & Duncan Aq Moore & Alfredo Yegros-Yegros, 2022. "Responding to a disease with resources from other diseases: Evidence from Zika vaccine research dynamics [Protective Efficacy of Multiple Vaccine Platforms against Zika Virus Challenge in Rhesus Mo," Science and Public Policy, Oxford University Press, vol. 49(6), pages 942-950.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Figueiredo, Paulo N., 2016. "Evolution of the short-fiber technological trajectory in Brazil's pulp and paper industry: The role of firm-level innovative capability-building and indigenous institutions," Forest Policy and Economics, Elsevier, vol. 64(C), pages 1-14.
    2. Cusmano, Lucia & Morrison, Andrea & Rabellotti, Roberta, 2010. "Catching up Trajectories in the Wine Sector: A Comparative Study of Chile, Italy, and South Africa," World Development, Elsevier, vol. 38(11), pages 1588-1602, November.
    3. Scherer, F. M., 2007. "Pharmaceutical Innovation," Working Paper Series rwp07-004, Harvard University, John F. Kennedy School of Government.
    4. Maureen McKelvey & Bastian Rake, 2012. "Research Network Position and Innovative Performance: Evidence from the Pharmaceutical Industry," Jena Economics Research Papers 2012-021, Friedrich-Schiller-University Jena.
    5. Iain M. Cockburn & Rebecca M. Henderson, 2001. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry," NBER Chapters, in: Innovation Policy and the Economy, Volume 1, pages 1-34, National Bureau of Economic Research, Inc.
    6. Ronnie Ramlogan & Davide Consoli, 2014. "Dynamics of collaborative research medicine: the case of glaucoma," The Journal of Technology Transfer, Springer, vol. 39(4), pages 544-566, August.
    7. Manuel Hermosilla & Jorge Lemus, 2018. "Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 21-52, National Bureau of Economic Research, Inc.
    8. Toole, Andrew A., 2012. "The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry," Research Policy, Elsevier, vol. 41(1), pages 1-12.
    9. Soh, Pek-Hooi & Subramanian, Annapoornima M., 2014. "When do firms benefit from university–industry R&D collaborations? The implications of firm R&D focus on scientific research and technological recombination," Journal of Business Venturing, Elsevier, vol. 29(6), pages 807-821.
    10. Grimpe, Christoph & Hussinger, Katrin, 2008. "Formal and Informal Technology Transfer from Academia to Industry: Complementarity Effects and Innovation Performance," ZEW Discussion Papers 08-080, ZEW - Leibniz Centre for European Economic Research.
    11. Srikanth Paruchuri & Atul Nerkar & Donald C. Hambrick, 2006. "Acquisition Integration and Productivity Losses in the Technical Core: Disruption of Inventors in Acquired Companies," Organization Science, INFORMS, vol. 17(5), pages 545-562, October.
    12. Veugelers, Reinhilde & Hottenrott, Hanna & Lopes Bento, Cindy, 2014. "Direct and Cross-Scheme Effects in a Research and Development Subsidy Program," CEPR Discussion Papers 10181, C.E.P.R. Discussion Papers.
    13. Ashish Arora & Sharon Belenzon & Andrea Patacconi, 2015. "Killing the Golden Goose? The Decline of Science in Corporate R&D," NBER Working Papers 20902, National Bureau of Economic Research, Inc.
    14. Toole, Andrew A., 2011. "The impact of public basic research on industrial innovation: Evidence from the pharmaceutical industry," ZEW Discussion Papers 11-063, ZEW - Leibniz Centre for European Economic Research.
    15. repec:wip:wpaper:4 is not listed on IDEAS
    16. Moritz Müller & Robin COWAN & Geert Duysters & Nicolas JONARD, 2009. "Knowledge Structures," Working Papers of BETA 2009-24, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
    17. Cassiman, Bruno & Veugelers, Reinhilde & Arts, Sam, 2018. "Mind the gap: Capturing value from basic research through combining mobile inventors and partnerships," Research Policy, Elsevier, vol. 47(9), pages 1811-1824.
    18. Iain Cockburn & Rebecca Henderson & Scott Stern, 1999. "The Diffusion of Science-Driven Drug Discovery: Organizational Change in Pharmaceutical Research," NBER Working Papers 7359, National Bureau of Economic Research, Inc.
    19. Subramanian, Annapoornima M. & Lim, Kwanghui & Soh, Pek-Hooi, 2013. "When birds of a feather don’t flock together: Different scientists and the roles they play in biotech R&D alliances," Research Policy, Elsevier, vol. 42(3), pages 595-612.
    20. Antonio Malva & Stijn Kelchtermans & Bart Leten & Reinhilde Veugelers, 2015. "Basic science as a prescription for breakthrough inventions in the pharmaceutical industry," The Journal of Technology Transfer, Springer, vol. 40(4), pages 670-695, August.
    21. Hottenrott, Hanna & Lopes-Bento, Cindy & Veugelers, Reinhilde, 2017. "Direct and cross scheme effects in a research and development," Research Policy, Elsevier, vol. 46(6), pages 1118-1132.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:39:y:2010:i:10:p:1277-1288. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/respol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.